Clinical Trials List
Protocol NumberM22-132
Active
2022-06-01 - 2029-09-30
Phase I/II
Recruiting3
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Tzu-Ting Chen 無
- 王秀慈 無
- Ching-Chan Lin 無
- Chi-Ching Chen 無
- 王幸婷 無
- Ming-Yu Lien 無
- Yu-Min Liao 無
- 陳珈妤 無
- Che-Hung Lin 無
- 鄭富銘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ting Hsu 無
- Ya-Ping Chen 無
- Chun-Hui Lee 無
- 顏志傑 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jyh-Pyng Gau 未分科
- Hao-Yuan Wang 無
- 蔡淳光 無
- 張乃文 無
- Liang-Tsai Hsiao 無
- 陳玟均 無
- Chia-Jen Liu 無
- Ting-An Lin 無
- 吳嘉紘 Division of Radiology
- Yao-Chung Liu 無
- Sheng-Hsuan Chien 無
- 陳蓉宣 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
496 participants
